SHPK expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.448600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.768000E-01
Normal-vs-Stage2
2.131400E-01
Normal-vs-Stage3
5.921500E-02
Normal-vs-Stage4
1.027190E-01
Stage1-vs-Stage2
4.835800E-01
Stage1-vs-Stage3
4.308800E-01
Stage1-vs-Stage4
4.910200E-01
Stage2-vs-Stage3
4.388600E-01
Stage2-vs-Stage4
5.362200E-01
Stage3-vs-Stage4
8.586800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.528600E-01
Normal-vs-AfricanAmerican
9.871600E-01
Normal-vs-Asian
9.818000E-02
Caucasian-vs-AfricanAmerican
1.964390E-01
Caucasian-vs-Asian
1.381800E-01
AfricanAmerican-vs-Asian
2.845800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.501400E-01
Normal-vs-Female
3.517800E-01
Male-vs-Female
8.288400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.587400E-01
Normal-vs-Age(41-60Yrs)
4.905800E-01
Normal-vs-Age(61-80Yrs)
2.857400E-01
Normal-vs-Age(81-100Yrs)
4.695800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.234000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.763000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.059200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.525700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.407000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.548800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.412400E-02
Normal-vs-Daily Drinker
1.116820E-01
Normal-vs-Weekly Drinker
2.632400E-01
Normal-vs-Occasional Drinker
5.310400E-01
Normal-vs-Social Drinker
7.535200E-01
Non Drinker-vs-Daily Drinker
8.004200E-01
Non Drinker-vs-Weekly Drinker
7.024600E-01
Non Drinker-vs-Occasional Drinker
3.553800E-01
Non Drinker-vs-Social Drinker
3.821700E-02
Daily Drinker-vs-Weekly Drinker
6.009800E-01
Daily Drinker-vs-Occasional Drinker
2.791200E-01
Daily Drinker-vs-Social Drinker
4.557900E-02
Weekly Drinker-vs-Occasional Drinker
6.169000E-01
Weekly Drinker-vs-Social Drinker
2.056800E-01
Occasional Drinker-vs-Social Drinker
4.986000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.261600E-01
Normal-vs-Grade 2
9.059800E-01
Normal-vs-Grade 3
7.876400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.012400E-01
Grade 1-vs-Grade 3
6.260000E-01
Grade 1-vs-Grade 4
5.261600E-01
Grade 2-vs-Grade 3
2.065800E-02
Grade 2-vs-Grade 4
9.059800E-01
Grade 3-vs-Grade 4
7.876400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.944300E-02
Normal-vs-NonDiabetic
4.192600E-01
Diabetic-vs-NonDiabetic
4.255500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.439800E-01
Normal-vs-NoPancreatitis
3.477000E-01
Pancreatitis-vs-NoPancreatitis
8.508600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.418400E-01
Normal-vs-N1
1.844350E-01
N0-vs-N1
3.146600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.764600E-01
Normal-vs-TP53-NonMutant
7.827200E-01
TP53-Mutant-vs-TP53-NonMutant
1.809600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
